A STTR Phase I contract was awarded to 1109 Bravo in November, 2021 for $49,999.0 USD from the U.S. Department of Defense and United States Air Force.
1109 BRAVO’s patented NeuroPak is a light-weight wearable training device designed with the intent of increasing Warfighter lethality on the battlefield and sustaining resiliency in the garrison-training environment. The system accelerates neural adaptati